Canada· CA-DIN-02389975
TRETTEN
A catridecacog product containing catridecacog, registered in Canada by NOVO NORDISK CANADA INC. The same ATC class is registered in 11 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Catridecacog is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD11 (catridecacog), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 7 of them publish a price we can compare per daily dose
Catridecacog · ATC B02BD11
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- CATRIDECACOG
- Manufacturer
- NOVO NORDISK CANADA INC
- Country
- Canada (CA)
- ATC code
- B02BD11
- ATC class
- Catridecacog
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Catridecacog in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNovoThirteen 2,500unit powder and solvent for solution for injection vialsImported (Denmark)
- CzechiaNOVOTHIRTEENNovo Nordisk A/S, Bagsvaerd
- SpainNOVOTHIRTEEN 2500 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLENovo Nordisk A/S
- FinlandNovothirteenNovo Nordisk A/S
- IcelandNovoThirteenNovo Nordisk A/S
- ItalyNOVOTHIRTEEN*1 flaconcino EV 2.500 Unita' Internazionali + 1 flaconcino 3,2 mlNOVO NORDISK A/S
- Japanカトリデカコグ（遺伝子組換え）ノボ ノルディスク ファーマ
- NetherlandsNovoThirteen, poeder en oplosmiddel voor oplossing voor injectieNovo Nordisk A.S.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Novothirteen
- Norway · Novothirteen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5cf6190-40c1-44d4-841b-8f55347cf6fc GET /v1/drugs/d5cf6190-40c1-44d4-841b-8f55347cf6fc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02389975",
"form": "POWDER FOR SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "B02BD11",
"schedule": [
"Schedule D"
],
"drug_code": "87544",
"strengths": [
"2500 UNIT"
],
"ahfs_class": null,
"substances": [
"CATRIDECACOG"
],
"product_categorization": null
}See everything about catridecacog.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.